HER2 | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

3 April 2024

Carisma switches cells

Trial results

20 March 2024

BioNTech has some cancer convincing to do

Regulatory

7 March 2024

Zymeworks wakes up to the Enhertu threat

Data insights

22 February 2024

Deal analysis part two – the good

A look at big oncology deals since 2016 finds outright success stories hard to come by.

Attendees at ESMO meeting

Conferences Trial results

17 October 2023

ESMO 2023 – Merus gets a pre-meeting boost

Conferences

4 September 2023

ESMO 2023 preview – conjugates, bispecifics and more

Deals Trial results

31 August 2023

DualityBio and BioNTech take on Enhertu in HER2 low

Subscribe to HER2